Drug Discovery World

JANUARY 9, 2023

Using gene engineering, we are repurposing cancer cells to develop a therapeutic that kills tumour cells and stimulates the immune system to both destroy primary tumors and prevent cancer.” . The researchers also built a two-layered safety switch into the cancer cell, which can eradicate the therapeutic tumour cells if needed.

Scientist 52

Scientist Gene Editing Gene Engineer 52

XTalks

DECEMBER 13, 2023

The landmark approvals were awarded to bluebird bio’s Lyfgenia (lovo-cel) and Vertex Pharmaceuticals and CRISPR Therapeutics’ jointly developed Casgevy (exa-cel). The revolutionary CRISPR/Cas9 technology was discovered by Jennifer Doudna and CRISPR Therapeutics co-founder Emmanuelle Charpentier who both shared the 2020 Nobel Prize for it.

Gene Therapy 98

Gene Therapy FDA Approval Gene In-Vivo 98

XTalks

OCTOBER 12, 2022

However, the role of MRI in new drug clinical trials can involve diagnosis of lesions and determination of their severity, early identification of therapeutic responders to drug treatment and treatment monitoring and follow-up. For most of this time, MRI mainly was used for qualitative interpretation and simple structural measurements.

Clinical Trials 93

Clinical Trials Clinical Trials Trials Drugs 93

XTalks

JANUARY 19, 2024

Therapeutic radiopharmaceuticals are particularly used in the treatment of cancer. Therapeutic radiopharmaceuticals deliver beta or alpha radiation, which destroys diseased cells, such as cancer cells. billion influx into radiopharmaceuticals which underscores the potential and robust growth in this therapeutic area.

DNA 66

DNA Radiology FDA Approval Development 66